Nicotine’s Effects on Schizophrenia-like Symptoms in a Mice Model: Time Matters
Authors:
- Ana Carolina Dutra-TavaresADAna Carolina Dutra-Tavares
- Luciana Araújo CoutoLCLuciana Araújo Couto
- Thainá P. SouzaTSThainá P. Souza
- Anais Bandeira-MartinsABAnais Bandeira-Martins
- Juliana Oliveira SilvaJSJuliana Oliveira Silva
- Claudio C. FilgueirasCFClaudio C. Filgueiras
- Anderson Ribeiro-CarvalhoARAnderson Ribeiro-Carvalho
- Alex C. ManhãesAMAlex C. Manhães
- Yael Abreu-VillaçaYAYael Abreu-Villaça
Open Access
- 25 August 2024
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 14 (9) , 855
Abstract
Tobacco consumption in schizophrenia (SCHZ) patients is highly prevalent. Data support the occurrence of sequential events during comorbidity establishment, and both smoking first, SCHZ second and SCHZ first, smoking second sequences have been proposed. To investigate whether these two possibilities lead to distinct outcomes of comorbidity, we used a phencyclidine-induced SCHZ model and nicotine exposure as a surrogate of smoking. C57Bl/6 mice were submitted to a protocol that either began with 4 days of phencyclidine exposure or 4 days of nicotine exposure. This period was followed by 5 days of combined phencyclidine + nicotine exposure. Locomotor sensitization and pre-pulse inhibition (PPI) were assessed due to their well-known associations with SCHZ as opposed to rearing, an unrelated behavior. Nicotine priming potentiated phencyclidine-evoked sensitization. However, nicotine exposure after SCHZ modeling did not interfere with phencyclidine’s effects. In the PPI test, nicotine after SCHZ modeling worsened the phencyclidine-evoked deficiency in males. In contrast, nicotine priming had no effects. Regarding rearing, nicotine priming failed to interfere with phencyclidine-mediated inhibition. Similarly, phencyclidine priming did not modify nicotine-mediated inhibition. The present results indicate that the sequence, either SCHZ-first or nicotine-first, differentially impacts comorbidity outcomes, a finding that is relevant for the identification of mechanisms of nicotine interference in the neurobiology of SCHZ.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (E-26/200.957/2021, E-26/210.105/2018, SEI-260003/001135/2020, E-26/202.266/2018, 304368/2020-2)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq-Brazil) (E-26/200.957/2021, E-26/210.105/2018, SEI-260003/001135/2020, E-26/202.266/2018, 304368/2020-2)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ-Brazil) (E-26/200.957/2021, E-26/210.105/2018, SEI-260003/001135/2020, E-26/202.266/2018, 304368/2020-2)
- Faperj-Brazil (E-26/200.957/2021, E-26/210.105/2018, SEI-260003/001135/2020, E-26/202.266/2018, 304368/2020-2)
- CNPq-Brazil (E-26/200.957/2021, E-26/210.105/2018, SEI-260003/001135/2020, E-26/202.266/2018, 304368/2020-2)
This publication has 120 references indexed in Scilit:
- Trends in Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders, 2006-2019JAMA, 2022
- Comorbidity of Severe Psychotic Disorders With Measures of Substance UseJAMA Psychiatry, 2014
- Trends in Smoking Among Adults With Mental Illness and Association Between Mental Health Treatment and Smoking CessationJAMA, 2014
- Effects of nicotine on sensorimotor gating impairment induced by long-term treatment with neurotoxic NMDA antagonismNeurotoxicity Research, 2008
- Nicotine and nonnicotine factors in cigarette addictionPsychopharmacology, 2005
- Cellular and synaptic mechanisms of nicotine addictionJournal of Neurobiology, 2002
- Effects of α4/β2- and α7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and micePsychopharmacology, 2001
- Is the dopaminergic system involved in the central effects of nicotine in mice?Psychopharmacology, 1993
- Sensorimotor Gating and SchizophreniaArchives of General Psychiatry, 1990
- An assessment of the spontaneous activity of rats administered morphine, phencyclidine, or nicotine using automated and observational methodsPsychopharmacology, 1984